Research and Markets: Global Active Pharmaceutical Ingredient Market Trends, bi13281359 DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/b7692a/global_active_phar) has announced the addition of the "Global Active Ingredient Market (Api) Trends, Competitive Landscape And Forecasts (2011-2016)" report to offering. The Development the High Potency Active Ingredient (HPAPI) and Biogeneric drugs boosting ..

Research on solubility yields promise for pharmaceutical, other industries bi13281359 A method for increasing solubility (the ability of one substance to dissolve another), developed by a graduate student has yielded promising commercial benefits for industry, particularly s, cosmetics and agriculture

Pharmaceutical Raw Material Manufacturing China: Industry Set to Benefit F bi13281359 In the five years through 2016, the international medical market expand by between 10% and 13%, and the Raw Material Manufacturing industry therefore increase steadily. According to IBISWorld, China has become the world's third largest medicine market. With billions of dollars? worth of patents set to expire the next few years, industry revenue ..

TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco bi13281359 CHENGDU, China , Dec. 20, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Inc. (NYSE Amex: TPI), a company that specializes the research, development and sale of patented bio ..

PCI Synthesis Completes R&D Expansion bi13281359 NEWBURYPORT, MA-- - PCI Synthesis, Inc. , a 12-year-old custom chemical manufacturer of new chemical entities , generic active ingredients , and other specialty chemical products, announced ..

Vivimed Labs hopes to cash on Uquifa buy to double turnover to Rs 1,000 cr bi13281359 Vivimed Labs Ltd hoping to cash on the global market potential for formulations post acquisition of Spain-based active ingredients maker, Uquifa, early month

PCI Synthesis Announces 8th Successful FDA Inspection bi13281359 PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active ingredients (APIs), and other specialty chemical products, announced the successful completion of eighth FDA inspection of the company's commercial manufacturing site Newburyport, Mass..

BS People: Subramanyam Maddala bi13281359 US-based Albany Molecular Research Inc (AMRI) seems to have found the right person to head India operations. The medicine chemistry company, struggling flat growth numbers and losses from global operations, sees growth research as well as the API (active ingredients) business to come from part of the world

Vivimed buys Uquifa Latin America for $55 m bi13281359 Hyderabad-based Vivimed Labs Ltd has acquired Latin American active ingredients manufacturer Uquifa for $55 million. The 75-year-old Uquifa has operations Spain and Mexico a gross asset base of $100 million

Ferro Pfanstiehl Laboratories ? Capture Your Vision bi13281359 For more than 40 years, Ferro Pfanstiehl Laboratories, Inc., (FPL) a wholly-owned subsidiary of Ferro Corporation (NYSE: FOE), manufactures clinical and commercial quantities of active ingredients (APIs), highly potent or highly cytotoxic active ingredients (HPAPIs), advanced intermediates, and other small molecule new chemical entities (NCEs)

ScinoPharm - Brand Quality Asian Advantages bi13281359 ScinoPharm offers global Active Ingredients (API) customers a unique combination of Brand quality the advantages of proven Taiwanese R&D and manufacturing expertise coupled ScinoPharm?s low cost Mainland China process development and upstream manufacturing personnel and facilities

Pulmatrix Presents Data on iSPERSE for Inhaled Combination Drug Therapies, In bi13281359 Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that iSPERSE? inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose blending for an effective therapeutic dose of the active ingredients Advair® ..

TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco bi13281359 CHENGDU, China , Dec. 20, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Inc. (NYSE Amex: TPI), a company that specializes the research, development and sale of patented bio ..

Tapeware Backup Software - Home